Victorien Monguillon: The Hidden Burden of Non-Major Extracranial Bleeding in Oral Anticoagulant Therapy
Victorien Monguillon, Research Fellow at TIMI Study Group, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Circulation, adding:
“Congrats Deborah Siegal and the team for this very well executed analysis highlighting the burden of extracranial non major clinically relevant bleeding with oral anticoagulant!
Worth the read!”
Title: Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis
Authors: Deborah M. Siegal, Marc Carrier, M. Cecilia Bahit, Jackie Bosch, Alexander P. Benz, Brian Bergmark, Robert P. Giugliano, Christopher B. Granger, Victorien Monguillon, Martin O’Donnell, Jonas Oldgren, Manesh R. Patel, Rohin K. Reddy, Lars Wallentin, Qilong Yi, Andre Zimerman, John Eikelboom
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines
-
Aug 9, 2026, 08:18Fawaz AlOtaibi: Why Experts Are Challenging the New Stroke Guideline
-
Aug 9, 2026, 08:08Jason Carney: Addressing the National Blood Shortage Through AI-Driven Patient Blood Management
-
Aug 9, 2026, 07:54Hamdy Alkady: FDA Approves the First Oral PCSK9 Inhibitor